17.95
price up icon5.84%   0.99
after-market Dopo l'orario di chiusura: 17.95
loading
Precedente Chiudi:
$16.96
Aprire:
$18.225
Volume 24 ore:
435.74K
Relative Volume:
0.59
Capitalizzazione di mercato:
$1.46B
Reddito:
$288.00K
Utile/perdita netta:
$-228.06M
Rapporto P/E:
-4.2235
EPS:
-4.25
Flusso di cassa netto:
$-168.82M
1 W Prestazione:
+6.91%
1M Prestazione:
+22.03%
6M Prestazione:
-4.32%
1 anno Prestazione:
+14.99%
Intervallo 1D:
Value
$17.94
$18.44
Intervallo di 1 settimana:
Value
$16.46
$18.44
Portata 52W:
Value
$9.90
$27.20

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Name
Nome
Viridian Therapeutics Inc
Name
Telefono
617.272.4600
Name
Indirizzo
221 CRESCENT STREET, WALTHAM
Name
Dipendente
143
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
VRDN's Discussions on Twitter

Confronta VRDN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
VRDN
Viridian Therapeutics Inc
17.95 1.38B 288.00K -228.06M -168.82M -4.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-19 Downgrade Wells Fargo Overweight → Equal Weight
2024-11-25 Iniziato TD Cowen Buy
2024-09-11 Reiterato Needham Buy
2024-06-11 Iniziato Wolfe Research Outperform
2024-06-06 Iniziato Goldman Buy
2024-05-09 Downgrade B. Riley Securities Buy → Neutral
2024-05-09 Downgrade Ladenburg Thalmann Buy → Neutral
2023-06-14 Iniziato BTIG Research Buy
2023-06-14 Ripresa Credit Suisse Outperform
2023-05-30 Iniziato RBC Capital Mkts Outperform
2023-04-17 Iniziato Wells Fargo Overweight
2023-03-30 Iniziato Stifel Buy
2022-12-19 Iniziato Cowen Outperform
2022-12-19 Iniziato Needham Buy
2022-12-16 Iniziato Credit Suisse Outperform
2022-12-01 Iniziato H.C. Wainwright Buy
2022-06-23 Iniziato B. Riley Securities Buy
2021-11-18 Iniziato SVB Leerink Outperform
2021-10-12 Iniziato Evercore ISI Outperform
2021-01-25 Iniziato Ladenburg Thalmann Buy
Mostra tutto

Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie

pulisher
Jul 22, 2025

Is Viridian Therapeutics Inc. a good long term investmentOutstanding risk-reward balance - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Viridian Therapeutics Inc. stock priceFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Viridian Therapeutics Inc. stockOutperformance with explosive growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Viridian Therapeutics Inc. stock attracts strong analyst attentionBreakout Level Watch - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Viridian Therapeutics Inc. Stock Analysis and ForecastSuperior returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Teacher Retirement System of Texas Decreases Stock Holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jul 21, 2025
pulisher
Jul 19, 2025

(VRDN) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 19, 2025
pulisher
Jul 19, 2025

Principal Financial Group Inc. Acquires 30,392 Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jul 19, 2025
pulisher
Jul 17, 2025

Viridian Therapeutics’ Veligrotug Shows Durable Proptosis Response in Phase 3 TED Trial - MSN

Jul 17, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Viridian Therapeutics Inc. stock price move sharplyFast Moving Stock Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Viridian Therapeutics Inc. stock performs during market volatilitySafety First Trading Signals - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Evercore Maintains Viridian Therapeutics(VRDN.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛

Jul 12, 2025
pulisher
Jul 12, 2025

Amalgamated Bank Has $34,000 Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Evercore ISI Lowers Viridian Therapeutics Price Target to $38 - AInvest

Jul 11, 2025
pulisher
Jul 10, 2025

Viridian Therapeutics Sees Relative Strength Rating Improve To 79 - MSN

Jul 10, 2025
pulisher
Jul 08, 2025

(VRDN) Investment Analysis - news.stocktradersdaily.com

Jul 08, 2025
pulisher
Jul 07, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Jul 07, 2025
pulisher
Jul 03, 2025

Viridian Therapeutics: Fueling R&D Breakthroughs Through Strategic Equity Incentives - AInvest

Jul 03, 2025
pulisher
Jul 01, 2025

Is Viridian Therapeutics (NASDAQ:VRDN) A Risky Investment? - simplywall.st

Jul 01, 2025
pulisher
Jun 28, 2025

(VRDN) On The My Stocks Page - news.stocktradersdaily.com

Jun 28, 2025
pulisher
Jun 17, 2025

When (VRDN) Moves Investors should Listen - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 15, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives $37.56 Average Target Price from Analysts - Defense World

Jun 15, 2025
pulisher
Jun 13, 2025

Viridian Therapeutics’ SWOT analysis: promising TED treatment stock faces pivotal year - Investing.com

Jun 13, 2025
pulisher
Jun 11, 2025

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Viridian Therapeutics: The Song Remains The Same (NASDAQ:VRDN) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Viridian Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025
pulisher
Jun 07, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.22 Million Stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Where are the Opportunities in (VRDN) - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 05, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | VRDN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jun 05, 2025

Viridian Therapeutics Inc Azioni (VRDN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):